Glycemic and lipid control in patients with diabetes at time of myocardial infarction
-
Published:2024-09
Issue:5
Volume:82
Page:865-872
-
ISSN:0003-4509
-
Container-title:Annales Pharmaceutiques Françaises
-
language:en
-
Short-container-title:Annales Pharmaceutiques Françaises
Author:
Lacqua Christelle,
Adam Héloïse,
Zeller Marianne,
Vadot Lucie,
Bichat Florence,
Maza Maud,
Cottin Yves,
Boulin MathieuORCID
Reference16 articles.
1. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS);Mach;Eur Heart J,2020
3. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;Sarwar;Lancet,2010
4. Trends in diabetes treatment and control in U.S. adults, 1999-2018;Fang;N Engl J Med,2021
5. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018;Wang;JAMA,2021